Flightpath Biosciences Begins Human Clinical Testing of the World’s First Narrow-Spectrum Antibiotic Targeting Lyme Disease
Accesswire
*DETROIT, MI / ACCESSWIRE / May 10, 2024 / *Flightpath Biosciences Inc., a clinical-stage life sciences company developing..